GlassScriptPhysician profile
Harvey W Chim
NPI 1750581120
$43,971.19
in general payments reported to CMS, 2019-2025
31 companies · $6,310 in 2025
The $6,310 reported for 2025 was more than what 93% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $604 · 2021: $7,830 · 2022: $18K · 2023: $3,204 · 2024: $6,945 · 2025: $6,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,749 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,375 · Honoraria: $2,500 · Travel and Lodging: $1,735 · Entertainment: $99.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,749.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,375.00 |
| Honoraria | $2,500.00 |
| Travel and Lodging | $1,734.58 |
| Entertainment | $99.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $18,693.81 | 2019-2025 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Integra Lifesciences Corporation | $9,352.83 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alafair Biosciences, INC. | $4,437.93 | 2020-2025 | Versawrap |
| Tulavi Therapeutics, INC. | $2,886.28 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Checkpoint Surgical, INC | $1,999.66 | 2020-2025 | Checkpoint Stimulators |
| Polynovo North America LLC | $1,355.46 | 2021-2025 | Novosorb Btm |
| Abbvie INC. | $600.00 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Kerecis Limited | $479.95 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Access Pro Medical, LLC | $476.90 | 2023 | Matriderm |
| Depuy Synthes Sales INC. | $400.08 | 2025 | Matrixcombo, Matrixmidface, Matrixmandible |
| Tela Bio, INC. | $350.68 | 2019-2022 | |
| Sientra, INC. | $325.02 | 2019-2020 | |
| Skeletal Dynamics INC | $284.69 | 2025 | Implate, Align, Ijs |
| Avita Medical Americas, LLC | $267.58 | 2025 | Permeaderm, Recell, Cohealyx |
| Musculoskeletal Transplant Foundation INC. | $252.80 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $182.82 | 2024 | Acumed |
| Sonex Health, INC. | $158.35 | 2024 | Sx-One Microknife |
| Becton, Dickinson and Company | $153.09 | 2025 | Phasix Mesh |
| Allergan, INC. | $150.00 | 2019 | |
| Acera Surgical, INC. | $132.09 | 2025 | Restrata Wound Matrix |
| Renerve LTD | $128.22 | 2025 | Nervalign Nerve Cuff |
| Imbed Biosciences INC. | $125.91 | 2022 | |
| Acell, INC. | $120.81 | 2019 | |
| Smith+Nephew, INC. | $120.80 | 2025 | Renasys Touch, Pico 14 |
| Integrum INC. | $120.04 | 2022 | |
| Trice Medical, INC. | $117.90 | 2020-2024 | |
| Mentor Worldwide LLC | $115.39 | 2025 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Cook Medical LLC | $86.36 | 2019 | |
| Baxter Healthcare | $52.40 | 2025 | |
| Biocomposites INC | $34.65 | 2025 | Stimulan |
| Onkos Surgical, INC. | $8.69 | 2023 | Eleos Limb Salvage System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Chim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.